|Bid||54.57 x 800|
|Ask||54.61 x 900|
|Day's Range||54.45 - 54.93|
|52 Week Range||47.88 - 65.86|
|Beta (5Y Monthly)||0.22|
|PE Ratio (TTM)||23.87|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jul 08, 2021|
|1y Target Est||62.37|
Subscribe to Yahoo Finance Plus to view Fair Value for RDY
Dr. Reddy's (RDY) earnings and sales beat estimates in second-quarter fiscal 2023.
HYDERABAD, India & PRINCETON, N.J., October 11, 2022--World Economic Forum recognises Dr. Reddy’s Hyderabad factory as part of its Global Lighthouse Network.
HYDERABAD, India & PRINCETON, N.J., September 07, 2022--Dr. Reddy’s Laboratories Ltd. today announced the launch, in the U.S. market, of Lenalidomide Capsules.